ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1645042
Global epidemiology and resistance-related mutations of ceftazidime-avibactam-resistant Klebsiella pneumoniae strains
Provisionally accepted- 1China Medical University, Shenyang, China
- 2Nankai University School of Medicine, Tianjin, China
- 3The Seventh Medical Center of PLA General Hospital, Beijing, China
- 45th Medical Center of Chinese PLA General Hospital, Beijing, China
- 5Chinese PLA Center for Disease Control and Prevention, Beijing, China
- 6Beijing Aerospace General Hospital, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Understanding the molecular epidemiological characteristics and resistance-related mutations of global CAZ/AVI-R K. pneumoniae strains. Methods: Non-repetitive K. pneumoniae strains isolated from clinical and sewage samples were subjected to antimicrobial susceptibility testing and whole-genome sequencing (WGS). According to the E-test results, 37 and 11 CAZ/AVI-R K. pneumoniae strains were included from clinical and sewage samples, respectively. After applying the inclusion and exclusion criteria, 253 CAZ/AVI-R K. pneumoniae strains with complete genome sequences were retrieved from public databases. Sequence types (STs) and serotypes were identified using Kleborate. Antimicrobial resistance genes (ARGs), virulence factors, and plasmids were annotated using Abricate. Prokka, Roary, and IQtree2 were used for annotation, core gene alignment, and phylogenetic analysis, respectively. Mutations in outer membrane porins (OmpK35 and OmpK36) and efflux pumps (AcrA and AcrB) were analyzed and visualized using Miniprot and BioAider. Results: Through comprehensive annotation, we identified 43 STs, 37 capsular (K) serotypes, 5 O antigen serotypes, 27 plasmid types and 22 ISs, 135 virulence genes, and 10 macromolecular secretion systems were annotated. Prophages carrying ARGs were annotated in 106 strains. In total, 128 distinct ARGs were identified among 301 strains. The ARGs associated with CAZ/AVI resistance in K. pneumoniae strains mainly included the class B metallo-beta-lactamases (MBLs) genes, blaKPC-2, and blaKPC-3 variants. Analysis of porin mutations revealed that in OmpK35, the most common substitution among all strains from three collection sources was at position 28 (*aaK). OmpK36 exhibited the highest number of mutations among strains from three sources, with frequent changes at position 136 (T136G), 137 (-gacacc), and 349 (H349R). Some porin mutations were identified exclusively in strains isolated from hospital clinical samples by our research team. OmpK35 had a substitution at position 132 (E132K). OmpK36 had substitutions at positions 2 (K2S), 3 (V3L), and 146 (R146H), respectively. AcrA and AcrB had substitutions at positions 188 (T188A) and 716 (R716L), respectively. Conclusion: The combination of multiple drug resistance-related mutations leads to resistance to CAZ/AVI. The most common resistance-related mutations in strains from both public databases and those collected by our team are the coexistence of porins and efflux pump mutations, and carriage of MBLs genes.
Keywords: Klebsiella pneumoniae, Ceftazidime-avibactam resistance, resistance-related mutations, genome analysis, Outer membrane porins
Received: 11 Jun 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 Xie, Chen, Qi, Yuan, Long, Wu, Liu, Guo, Wang, Meng, Liu, Chen and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xiangzhao Meng, Beijing Aerospace General Hospital, Beijing, China
Xiong Liu, Chinese PLA Center for Disease Control and Prevention, Beijing, China
Yong Chen, Chinese PLA Center for Disease Control and Prevention, Beijing, China
Jie Liu, The Seventh Medical Center of PLA General Hospital, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.